Insiders · Profile

Jacobs Bette

Director at Shuttle Pharmaceuticals. Filing since 29 Dec 2022. CIK 0001953668

Company
Date
Role
Action
Shares
Amount
Of holding
13 Dec 2023
Director
Sold at will
4,157
$1.93K
13.3%
29 Dec 2022
Director
Sold, plan not stated
4,366
$7.01K
12.3%
2 decisions on file.